<DOC>
	<DOCNO>NCT00910260</DOCNO>
	<brief_summary>We plan investigate serum elevation 25 ( OH ) D UVB nb UVA1 therapy , order determine effect nowadays frequently use wavelength phototherapy vitamin D plasma level . We hope well understanding steady-state treatment-induced level vitamin D change well recognize impact phototherapy vitamin D synthesis skin , dimension vitamin D production expect course standard phototherapy potential gap vitamin D production compare physiological need supplement orally .</brief_summary>
	<brief_title>Impact UVB Narrow Band UVA1 Therapy Serum 25-hydroxyvitamin D Levels</brief_title>
	<detailed_description>This open observational study dermatological patient undergo phototherapy . In patient skin disease routinely give indication phototherapy UVB narrow-band ( UVB nb , 311nm ) UVA1 ( 340-400 nm ) , serum 25-hydroxyvitamin D , calcium , parathormone , phosphate albumin level measure , completion 12-week therapy ( 30 patient per group ) . Patients recruit department dermatology University Hospital ZÃ¼rich outpatient clinic . Following oral write consent , serum 25-hydroxyvitamin D , calcium , parathormone , phosphate albumin level measure therapy , one week start well completion UVB nb/UVA1 therapy . In parallel study patient ask fill questionnaire evaluate daily vitamin D consume ( milk milk product , fish , food enhance vitamin D , multivitamin supplement ) , sun exposure per week previous week , degree tanning , use sunscreen , DLQI Skindex-29 . A physical examination include clinical score available perform every `` checkpoint '' . During first physical examination Fitzpatrick-skin type patient record . The following participant characteristic record : age , weight , body mass index ( BMI ) , phototype , skin disease , comorbidities , usual medication , period year UVB nb/UVA1 therapy perform ( summer vs. winter ) , cumulative UVB nb/UVA1 dos .</detailed_description>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Hydroxycholecalciferols</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Calcifediol</mesh_term>
	<criteria>Inclusion criterion : 1 . Dermatological indication phototherapy UVB nb UVA1 2 . Oral write informed patient consent Exclusion criterion : 1 . Interruption light therapy 14 day 2 . Withdrawal consent participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>vitamin D level phototherapy</keyword>
</DOC>